Cargando…

Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation

Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukacs, Nicholas W., Prosser, Dina M., Wiekowski, Maria, Lira, Sergio A., Cook, Donald N.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193496/
https://www.ncbi.nlm.nih.gov/pubmed/11514610
_version_ 1782147484540207104
author Lukacs, Nicholas W.
Prosser, Dina M.
Wiekowski, Maria
Lira, Sergio A.
Cook, Donald N.
author_facet Lukacs, Nicholas W.
Prosser, Dina M.
Wiekowski, Maria
Lira, Sergio A.
Cook, Donald N.
author_sort Lukacs, Nicholas W.
collection PubMed
description Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3α is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3α, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3α and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma.
format Text
id pubmed-2193496
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21934962008-04-14 Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation Lukacs, Nicholas W. Prosser, Dina M. Wiekowski, Maria Lira, Sergio A. Cook, Donald N. J Exp Med Brief Definitive Report Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3α is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3α, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3α and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma. The Rockefeller University Press 2001-08-20 /pmc/articles/PMC2193496/ /pubmed/11514610 Text en © 2001 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Brief Definitive Report
Lukacs, Nicholas W.
Prosser, Dina M.
Wiekowski, Maria
Lira, Sergio A.
Cook, Donald N.
Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation
title Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation
title_full Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation
title_fullStr Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation
title_full_unstemmed Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation
title_short Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation
title_sort requirement for the chemokine receptor ccr6 in allergic pulmonary inflammation
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193496/
https://www.ncbi.nlm.nih.gov/pubmed/11514610
work_keys_str_mv AT lukacsnicholasw requirementforthechemokinereceptorccr6inallergicpulmonaryinflammation
AT prosserdinam requirementforthechemokinereceptorccr6inallergicpulmonaryinflammation
AT wiekowskimaria requirementforthechemokinereceptorccr6inallergicpulmonaryinflammation
AT lirasergioa requirementforthechemokinereceptorccr6inallergicpulmonaryinflammation
AT cookdonaldn requirementforthechemokinereceptorccr6inallergicpulmonaryinflammation